Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02632071
Title Phase I of ACY-1215 + Nab-paclitaxel in Breast Cancer
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Kevin Kalinsky
Indications

breast adenocarcinoma

Therapies

Nab-paclitaxel + Ricolinostat

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Columbia Irving University Medical Center New York New York 10032 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field